Nelfinavir contraindications

Revision as of 16:14, 9 January 2014 by Mohamed Moubarak (talk | contribs) (Created page with "__NOTOC__ {{Nelfinavir}} {{CMG}}; {{AE}} {{MM}} ==Contraindications== Coadministration of VIRACEPT is contraindicated with drugs that are highly dependent on CYP3A for cleara...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Nelfinavir
VIRACEPT® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

Contraindications

Coadministration of VIRACEPT is contraindicated with drugs that are highly dependent on CYP3A for clearance and for which elevated plasma concentrations are associated with serious and/or life-threatening events. These drugs and other contraindicated drugs (which may lead to reduced efficacy of nelfinavir) are listed in Table 3

References

Adapted from the FDA Package Insert.